Glucagon-like peptide-1 receptor analog use is associated with reduced thromboembolic events compared with dipeptidyl peptidase-4 inhibitors in rheumatoid arthritis patients: A global retrospective cohort study
Sign Up to like & getrecommendations! Published in 2025 at "Clinical Rheumatology"
DOI: 10.1007/s10067-025-07709-0
Abstract: Rheumatoid arthritis (RA) is an inflammatory disease associated with thromboembolic events. Glucagon-like peptide-1 (GLP-1) analogs, which are used in type 2 diabetes mellitus (T2DM), have shown potential anti-inflammatory effects, but their role in thrombotic events… read more here.
Keywords: glp analogs; thromboembolic events; mortality; thrombosis ... See more keywords
SUN-661 Impact of GLP-1 Analogs vs. Lipid Lowering Agents on Risk for Acute Pancreatitis in Hypertriglyceridemia: A TriNetX Analysis
Sign Up to like & getrecommendations! Published in 2025 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvaf149.171
Abstract: Abstract Disclosure: A. Kang: None. R. Devbhandari: None. Hypertriglyceridemia is a known risk factor for pancreatitis and management involves pursuing lifestyle modifications and lipid lowering agents such as statins and fibrates. Glucagon-like-peptide-1 (GLP-1) analogs are… read more here.
Keywords: glp analogs; lipid lowering; lowering agents; pancreatitis ... See more keywords
GLP-1 analog therapy and hemoglobin levels: Insights from a retrospective study
Sign Up to like & getrecommendations! Published in 2025 at "Saudi Medical Journal"
DOI: 10.15537/smj.2025.46.8.20240100
Abstract: ABSTRACT Objectives: To investigate the hematological impact of Glucagon-like peptide-1 (GLP-1) analogs, specifically changes in hemoglobin and ferritin levels. Glucagon-like peptide-1 analogs, pivotal in managing type 2 diabetes mellitus (T2DM) and obesity, exhibit diverse physiological… read more here.
Keywords: glp analogs; hemoglobin levels; glp analog; hemoglobin ... See more keywords
Impact of glucagon-like peptide 1 analogs on cognitive function among patients with type 2 diabetes mellitus: A systematic review and meta−analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.1047883
Abstract: Background Diabetes is an independent risk factor for cognitive impairment. However, little is known about the neuroprotective effects of glucagon-like peptide 1 (GLP-1) analogs on type 2 diabetes mellitus (T2DM). Herein, we assessed the impact… read more here.
Keywords: cognitive functioning; glucagon like; glp analogs; general cognitive ... See more keywords
GLP-1a: Going beyond Traditional Use
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23020739
Abstract: Glucagon-like peptide-1 (GLP-1) is a human incretin hormone derived from the proglucagon molecule. GLP-1 receptor agonists are frequently used to treat type 2 diabetes mellitus and obesity. However, the hormone affects the liver, pancreas, brain,… read more here.
Keywords: glp; use glp; glp going; brain ... See more keywords